Rockwell Medical, Inc. (RMTI): Price and Financial Metrics
GET POWR RATINGS... FREE!
RMTI Stock Summary
- With a market capitalization of $12,214,307, ROCKWELL MEDICAL INC has a greater market value than merely 4.36% of US stocks.
- With a price/sales ratio of 0.18, ROCKWELL MEDICAL INC has a higher such ratio than merely 4.45% of stocks in our set.
- In terms of volatility of its share price, RMTI is more volatile than 92.32% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to ROCKWELL MEDICAL INC are BC, BELFA, EFOI, VNT, and KODK.
- Visit RMTI's SEC page to see the company's official filings. To visit the company's web site, go to www.rockwellmed.com.
RMTI Valuation Summary
- RMTI's price/sales ratio is 0.2; this is 90% lower than that of the median Healthcare stock.
- RMTI's price/sales ratio has moved down 0.3 over the prior 243 months.
Below are key valuation metrics over time for RMTI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| RMTI | 2022-12-02 | 0.2 | 0.8 | -0.5 | -1.0 |
| RMTI | 2022-12-01 | 0.2 | 0.8 | -0.5 | -0.9 |
| RMTI | 2022-11-30 | 0.2 | 0.8 | -0.5 | -0.9 |
| RMTI | 2022-11-29 | 0.2 | 0.7 | -0.4 | -0.9 |
| RMTI | 2022-11-28 | 0.2 | 0.7 | -0.5 | -0.9 |
| RMTI | 2022-11-25 | 0.2 | 0.8 | -0.5 | -0.9 |
RMTI Growth Metrics
- The 4 year net cashflow from operations growth rate now stands at -127.82%.
- Its year over year net cashflow from operations growth rate is now at 13.33%.
- The 3 year net income to common stockholders growth rate now stands at 8.99%.
The table below shows RMTI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 68.829 | -25.846 | -25.26 |
| 2022-06-30 | 66.126 | -31.819 | -28.651 |
| 2022-03-31 | 62.581 | -30.851 | -32.084 |
| 2021-12-31 | 61.931 | -33.534 | -32.674 |
| 2021-09-30 | 61.762 | -33.077 | -32.396 |
| 2021-06-30 | 61.054 | -30.91971 | -32.165 |
RMTI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- RMTI has a Quality Grade of D, ranking ahead of 9.74% of graded US stocks.
- RMTI's asset turnover comes in at 0.825 -- ranking 30th of 681 Pharmaceutical Products stocks.
- IMGN, PTE, and BCDA are the stocks whose asset turnover ratios are most correlated with RMTI.
The table below shows RMTI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.825 | 0.014 | -0.801 |
| 2021-03-31 | 0.850 | 0.033 | -0.675 |
| 2020-12-31 | 0.863 | 0.044 | -0.730 |
| 2020-09-30 | 0.981 | 0.055 | -0.790 |
| 2020-06-30 | 1.151 | 0.049 | -0.908 |
| 2020-03-31 | 1.139 | 0.048 | -1.191 |
RMTI Price Target
For more insight on analysts targets of RMTI, see our RMTI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $5.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
RMTI Stock Price Chart Interactive Chart >
RMTI Price/Volume Stats
| Current price | $1.16 | 52-week high | $7.15 |
| Prev. close | $1.05 | 52-week low | $0.84 |
| Day low | $1.06 | Volume | 34,200 |
| Day high | $1.17 | Avg. volume | 95,777 |
| 50-day MA | $1.12 | Dividend yield | N/A |
| 200-day MA | $2.15 | Market Cap | 10.95M |
Rockwell Medical, Inc. (RMTI) Company Bio
Rockwell Medical is a biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. The company was founded in 1995 and is based in Wixom, Michigan.
Latest RMTI News From Around the Web
Below are the latest news stories about ROCKWELL MEDICAL INC that investors may wish to consider to help them evaluate RMTI as an investment opportunity.
Rockwell Medical Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues LagRockwell Medical ( NASDAQ:RMTI ) Third Quarter 2022 Results Key Financial Results Revenue: US$18.7m (up 17% from 3Q... |
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational ResultsWIXOM, Mich., November 14, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today provided an update on its overall business strategy and announced its financial and operational results for the third quarter ended September 30, 2022. |
Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from BaxterWIXOM, Mich., November 09, 2022--Rockwell Medical, Inc. ("Rockwell" or the "Company") (Nasdaq: RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, announced that the Company is reacquiring its distribution rights to its hemodialysis concentrates products from Baxter and has agreed to terminate the exclusive distribution agreement dated October 2, 2014. Exclusivity and other provi |
Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14WIXOM, Mich., October 17, 2022--Rockwell Medical, Inc. (Nasdaq:RMTI), a commercial healthcare company focused on providing life-sustaining products for patients suffering from blood disorders and diseases associated with the kidney, today announced that it will release its financial results for the third quarter ended September 30, 2022 on Monday, November 14, 2022. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET. |
Is Rockwell Medical, Inc. (NASDAQ:RMTI) Potentially Undervalued?While Rockwell Medical, Inc. ( NASDAQ:RMTI ) might not be the most widely known stock at the moment, it saw significant... |
RMTI Price Returns
| 1-mo | 29.06% |
| 3-mo | -27.95% |
| 6-mo | -22.15% |
| 1-year | -72.34% |
| 3-year | -95.21% |
| 5-year | -98.16% |
| YTD | -74.28% |
| 2021 | -59.41% |
| 2020 | -58.61% |
| 2019 | 7.96% |
| 2018 | -61.17% |
| 2017 | -11.15% |
Continue Researching RMTI
Want to do more research on Rockwell Medical Inc's stock and its price? Try the links below:Rockwell Medical Inc (RMTI) Stock Price | Nasdaq
Rockwell Medical Inc (RMTI) Stock Quote, History and News - Yahoo Finance
Rockwell Medical Inc (RMTI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...